Erik Huneker, CEO of Diabeloop

‌

Sunday, 16 January 2022
12pm (noon) PST (8pm GMT)
(NOTE: Special time)

Join Us:

Zoom: https://us02web.zoom.us/j/83379785062

YouTube: https://www.youtube.com/c/LOOPandLEARN

Starting off the new year with a bang, please join us to hear from Erik Huneker, CEO and Co-Founder of Diabeloop, a self-learning algorithm that automates and personalizes the treatment of T1D.

Erik is very interested in addressing OUR questions and engaging with us. To that, he has asked that you post ANY questions to the GoogleDoc linked below. 

In the world of emerging automated insulin delivery systems for diabetes, French company Diabeloop stands out for its design work. The company works on their designs with input from the people who will actually be using their products.

Company leaders have been researching and building this technology for a decade. They’ve worked directly with people with diabetes (PWDs) in the DIY #WeAreNotWaiting community to create a more customizable, practical system instead of the usual “engineering-driven” devices we’re used to.

Evidence of that can be seen in things like the Diabeloop “Zen Mode” feature, which lets users temporarily raise glucose targets slightly to avoid annoying alerts that would otherwise beep after every meal. There’s also a “Privacy Mode” that lets them shut off sharing features in case they need a break.

Erik Huneker, an engineer who graduated from the Ecole Polytechnique, is a tech and science enthusiast, who works in the medical device industry. In 2015, he founded Diabeloop with Dr. Guillaume Charpentier, a diabetologist and Chief Medical Officer of the company. Since 2016, he co-manages Diabeloop with Marc Julien, who graduated from INSEAD and has over 25 years of experience in consulting, investment and entrepreneurship.

As an aside, Diabeloop represents the new model of INTEROPERABILITY, allowing you to choose your pump and your CGM. This should be the standard! While the US FDA claims to be focusing on interoperability, not one single device has been approved yet in the US that offers interoperability. Yet there are several options available in the EU. If you are not pleased with this and want to participate in some advocacy for better options in the US, please contact Joanne Milo.

Dr. Laura Nally, Yale University

‌

Sunday, January 30, 2022
5:00 PM-7:00 PM PST.  (12am GMT)

Join us:

Zoom:https://us02web.zoom.us/j/87024790917

YouTube: https://www.youtube.com/c/LOOPandLEARN

Dr. Laura Nally is back to talk about T1D, Looping and Exercise! Once again, she is very excited to be presenting to Loop and Learn … and looks forward to a lively Q&A session. As always, the event will be recorded and available for viewing and sharing the following day on our YouTube Loop and Learn channel.

Laura Nally, MD, was diagnosed with T1D at the age of 6 years in 1990. She trained to become a pediatric endocrinologist at Stanford University, where she began Looping in 2018. While at Stanford, she spent 8 days hiking Mt. Whitney (14,505 ft), the tallest peak in the contiguous US, with 9 teens and 2 adults with T1D, and went on to write the first Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management.

She currently works at Yale University as an Assistant Professor and receives funding from the National Institutes of Health to study metabolic changes that occur on very low carbohydrate diets in youth with T1D. She also published the first case report of Looping in Pregnancy (click on the link below).

She spends her free time advocating to improve access and affordability of diabetes medications and supplies, serving as the legislative lead for the Connecticut #insulin4all Chapter of T1International.

Chris Wilson, CEO of Glucose Genius

‌

• We’re on a mission to transform fundamental understandings and assumptions about the management of T1D. The answers are in the data. You can’t build a sturdy house on a cracked foundation.
• What's the #math involved in #T1D? It's calculating the retrorocket burn intensity and timing required to (safely) maintain a stable orbit in a universe where the "gravitational constant" is constantly in flux- and with rockets that don't respond for 30 minutes after you press "fire"
• Your ISF is static, right? That’s how it’s programmed in your pump. That’s what your Endocrinologist told you a million years ago when you were diagnosed with T1D. But what if it isn’t?
• What if this fundamental thing that we all thought we knew about T1D isn’t actually true?

Erik Verhoef, CEO of Seagrove Partners

Sunday, 6 March 2022
5pm PST (12am GMT)

Erik Verhoef, President/CEO of Seagrove Partners

Topics: Current and Emerging Technologies for Type 1 Diabetes, Worldwide.

Click the link below to see Erik review the "50+ New CGM Companies" at the Fall 2021 DiabetesMine D-Data ExChange.

Seeing Double

‌

If you're seeing double-ended trend arrows in Nightscout, you're not alone.  In December, Dexcom made a change to its servers that triggered these double-ended trend arrows.  These arrows are annoying, but are primarily a display issue.  What should you do? 

1. Update your Nightscout site to 14.2.5 using our newest video - Update Nightscout, Fast and Easy, by clicking the link below. 
2. Delete "bridge" from your Heroku ENABLE config var, and select Upload Readings from within Loop/Settings/CGM.

#WeAreNotWaiting